pharmafocusAmerica Magazine
Issue 06 | 2025
- Foreword
- Strategy
- Research & Development
- Clinical Trials
- Manufacturing
- Information Technology
- Expert Talk
- Advertorials
- BioPharma ' Go to Digital Magazine
Issue 06
PREVIOUS ISSUE
Foreword
Exploring the New Era of Pharmaceutical Innovation
Across these pages thought leaders share perspectives that span the promise of biosimilars expanding patient access
Strategy
Resilient by Design
GxP Compliance and Supply Chain Innovation in the Post-Pandemic Era
The COVID pandemic served as a powerful stress test for the pharmaceutical industry It disrupted manufacturing lines
US Biosimilar Market Current Trends & Challenges
The Biologics Price Competition and Innovation Act BPCIA enacted on March was created to set up
Research & Development
AI in R&D Platforms
Platform or Perish The Data Infrastructure Divide
By investment in AI for pharmaceutical applications will increase from billion to billion
A Controversial Issue in Clinical Investigation for Rare Disease Drug Development
For approval of a test drug product under investigation the United States US Food and Drug Administration FDA
Clinical Trials
Enabling Successful Trial Recruitment through Centralized Technology Platforms
Recruitment and retention of participants are fundamental challenges in clinical research directly impacting the feasibility
Why Single-Arm Trials Are Gaining Ground in Oncology Approvals
The pace of innovation in oncology driven by personalized cancer treatment and highly targeted therapies
Leveraging Real World Evidence, Registries, and Decentralized Trials for Next Generation Innovation
The pharmaceutical industry is undergoing a fundamental transformation driven by the integration of realworld evidence
Manufacturing
Pharmaceutical 3D printing
Bringing compounding into the 21st century
Pharmaceutical D printing a technology vital for smallbatch personalised medicine has matured significantly
Navigating the Tariff Landscape
Strategic Shifts for Drug Development Supply Chains
As sweeping tariffs disrupt global trade drug developers face rising costs especially in complex biologics and antibodydrug
Information Technology
Artificial Intelligence Meets Pharmacovigilance
The Future of Drug and Device Safety Monitoring
Artificial intelligence AI refers to computer systems designed to carry out tasks typically associated with human
Data Governance in Life Sciences
In todays rapidly evolving digital landscape data has become a critical asset for organizations across all industries
Expert Talk
AI in Regulatory Affairs
Between Promise and Proof
AI adoption in regulatory functions truly gaining ground across biopharma or does it remain mostly confined
RNA, CAR-T & CRISPR
Engineering the Next Frontier of Medicine
CART has matured with approvals reimbursement and expanding use but now its optimizing not reinventing
Clinical Trial Modernization
Technological, Operational, and Regulatory Advances
The transformation of clinical trials is driven by a convergence of operational inefficiencies technological
How AI is Reshaping Compliance and Quality Management in the Life Sciences Sector in 2025
AI is shifting the role of quality professionals from messengers to datadriven decisionmakers Traditionally
Advertorials
High, Higher, HighCon
The pharmaceutical industry is in a constant race against time New diseases are always developing that require
Accelerating Biomarker Discovery Assays
Biomarker analysis is pivotal in modern drug discovery and development boosting therapeutic success rates
Revolutionizing Drug Discovery
Advancing Metabolite Identification with LC-MS and EAD
Liquid ChromatographyMass Spectrometry LCMS has emerged as one of the most powerful and versatile tools
BioPharma
Biotech Licensing and Collaborations
Bringing a biopharmaceutical product to market requires the alignment of multiple critical factors In an ever more